MENU
IFRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
InflaRx (IFRX) Earnings Date & Reports
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
IFRX is expected to report earnings to rise 193.00% to -5 cents per share on March 25
Q4'26
Est.
$-0.06
Q3'26
Beat
by $0.05
Q2'26
Missed
by $0.01
Q1'26
Beat
by $0.06
Q4'25
Est.
$-0.15
The last earnings report on November 03 showed earnings per share of -1 cents, beating the estimate of -7 cents. With 368.18K shares outstanding, the current market capitalization sits at 192.32M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
65
Web
https://www.inflarx.de